Publications by authors named "Kristin Reiche"

Claim this Profile
A
A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myeloma.
Michael Rade, David Fandrei, Markus Kreuz, Sabine Seiffert, Anja Grahnert, Kristin Reiche

Cancer Cell· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial dysfunction and proinflammatory state determine severe hematotoxicity and inferior outcome of CAR-T therapy.
Lukas Scheller, Xiang Zhou, Henry Loeffler-Wirth, Markus Kreuz, Sofie-Katrin Kadel, Kristin Reiche

Hemasphere· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR T-cell therapy induces remission in multiorgan IgG4-related disease with hepatobiliary involvement.
Verena Keitel, Michael C Kreissl, Tobias Goetze, Carola Dröge, Christina Katharina Kuhn, Kristin Reiche

J Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Implications of Splenomegaly in BCMA-Directed CAR T-Cell Therapy for Relapsed Myeloma.
Thomas C Wiemers, Maximilian Ferle, Jonas Ader, Veronika Sotikova, David Fandrei, Kristin Reiche

Transplant Cell Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ROR2-specific CAR T cells are effective against hematologic and solid tumors and well tolerated in mice.
Justus Weber, Michael Rade, Josefine Michael, Liz Therese Tony, Fabian Freitag, Kristin Reiche

Cell Rep Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in Europe.
Delphine Ammar, Carmen Sanges, David Henderson, Inga Schapitz, Michael Hudecek, Kristin Reiche

Cytotherapy· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design specifications for biomedical virtual twins in engineered adoptive cellular immunotherapies.
Ulrike Weirauch, Markus Kreuz, Colin Birkenbihl, Miriam Alb, Maria Quaranta, Kristin Reiche

NPJ Digit Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune cells play a critical role in cytokine- and endotoxin-mediated endothelial permeability.
Patricia Gogesch, Samira Ortega Iannazzo, Nicole Rupp, Joachim Rom, Markus Kreuz, Kristin Reiche

PLoS One· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapies.
Alexander Mazein, Oxana Lopata, Kristin Reiche, Katherina Sewald, Miriam Alb

Front Immunol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virtual twins for personalised CAR T-cell therapy in myeloma.
Kristin Reiche, Ulrike Weirauch, Markus Kreuz, Luise Fischer, Luuk Gras

Lancet Haematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging T-cell lymphomas after CAR T-cell therapy.
Till Braun, Florian Kuschel, Kristin Reiche, Maximilian Merz, Marco Herling

Leukemia· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Predicting progression events in multiple myeloma from routine blood work.
Maximilian Ferle, Nora Grieb, Markus Kreuz, Jonas Ader, Hartmut Goldschmidt, Kristin Reiche

NPJ Digit Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiomic profiling of T cell lymphoma after therapy with anti-BCMA CAR T cells and GPRC5D-directed bispecific antibody.
Till Braun, Michael Rade, Maximilian Merz, Hanna Klepzig, Florian Große, Kristin Reiche

Nat Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting progression events in multiple myeloma from routine blood work.
Maximilian Ferle, Nora Grieb, Markus Kreuz, Jonas Ader, Hartmut Goldschmidt, Kristin Reiche

NPJ Digit Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma.
David Fandrei, Sabine Seiffert, Michael Rade, Susanne Rieprecht, Nico Gagelmann, Kristin Reiche

Blood Cancer Discov· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune digital twins for complex human pathologies: applications, limitations, and challenges.
Anna Niarakis, Reinhard Laubenbacher, Gary An, Yaron Ilan, Jasmin Fisher, Kristin Reiche

NPJ Syst Biol Appl· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using interactive platforms to encode, manage and explore immune-related adverse outcome pathways.
Alexander Mazein, Muhammad Shoaib, Miriam Alb, Christina Sakellariou, Charline Sommer, Kristin Reiche

J Immunotoxicol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel strategies to assess cytokine release mediated by chimeric antigen receptor T cells based on the adverse outcome pathway concept.
Miriam Alb, Kristin Reiche, Michael Rade, Katherina Sewald, Peter Loskill

J Immunotoxicol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma.
Michael Rade, Nora Grieb, Ronald Weiss, Jaren Sia, Luise Fischer, Kristin Reiche

Nat Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Spatial Transcriptomics Browser for Discovering Gene Expression Landscapes across Microscopic Tissue Sections.
Maria Schmidt, Susanna Avagyan, Kristin Reiche, Hans Binder, Henry Loeffler-Wirth

Curr Issues Mol Biol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma.
Luise Fischer, Nora Grieb, Patrick Born, Ronald Weiss, Sabine Seiffert, Kristin Reiche

Leukemia· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A reliable transcriptomic risk-score applicable to formalin-fixed paraffin-embedded biopsies improves outcome prediction in localized prostate cancer.
Michael Rade, Markus Kreuz, Angelika Borkowetz, Ulrich Sommer, Conny Blumert, Kristin Reiche

Mol Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology.
Bouchra Derraz, Gabriele Breda, Christoph Kaempf, Franziska Baenke, Fabienne Cotte, Kristin Reiche

NPJ Precis Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A time-resolved meta-analysis of consensus gene expression profiles during human T-cell activation.
Michael Rade, Sebastian Böhlen, Vanessa Neuhaus, Dennis Löffler, Conny Blumert, Kristin Reiche

Genome Biol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and evaluation of gene fusions as a measure of genetic instability and disease prognosis in prostate cancer.
Carolin Schimmelpfennig, Michael Rade, Susanne Füssel, Dennis Löffler, Conny Blumert, Kristin Reiche

BMC Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis